103 related articles for article (PubMed ID: 7493362)
1. Use of anticytokeratin monoclonal anti-idiotypic antibodies to improve tumor:nontumor ratio in experimental radioimmunolocalization.
Ullén A; Sandström P; Ahlström KR; Sundström B; Nilsson B; Arlestig L; Stigbrand T
Cancer Res; 1995 Dec; 55(23 Suppl):5868s-5873s. PubMed ID: 7493362
[TBL] [Abstract][Full Text] [Related]
2. Idiotypic-anti-idiotypic antibody interactions in experimental radioimmunotargeting.
Sandström P; Johansson A; Ullén A; Rathsman S; Riklund-Ahlström K; Stigbrand T
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3073s-3078s. PubMed ID: 10541346
[TBL] [Abstract][Full Text] [Related]
3. Syngeneic anti-idiotypic antibodies eliminate excess radiolabeled idiotypes at experimental radioimmunolocalization.
Ullén A; Riklund Ahlström K; Makiya R; Stigbrand T
Cell Biophys; 1995 Aug; 27(1):31-45. PubMed ID: 7493397
[TBL] [Abstract][Full Text] [Related]
4. Experimental radioimmunotargeting combining nonlabeled, iodine-125-labeled, and anti-idiotypic anticytokeratin monoclonal antibodies: a dosimetric evaluation.
Rossi Norrlund R; Ullén A; Sandström P; Holback D; Johansson L; Stigbrand T; Hietala SO; Riklund Ahlström K
Cancer; 1997 Dec; 80(12 Suppl):2689-98. PubMed ID: 9406726
[TBL] [Abstract][Full Text] [Related]
5. Dosimetry of fractionated experimental radioimmunotargeting with idiotypic and anti-idiotypic anticytokeratin antibodies.
Rossi Norrlund R; Ullén A; Sandström P; Holback D; Johansson L; Stigbrand T; Hietala SO; Riklund Ahlström K
Cancer; 1997 Dec; 80(12 Suppl):2681-8. PubMed ID: 9406725
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of growth of HeLa cell tumours in nude mice by 125I-labeled anticytokeratin and antiPLAP monoclonal antibodies.
Riklund KE; Makiya R; Sundström B; Bäck O; Henriksson R; Hietala SO; Stigbrand T
Anticancer Res; 1991; 11(2):555-60. PubMed ID: 1712175
[TBL] [Abstract][Full Text] [Related]
7. Localization of complexed anticytokeratin 8 scFv TS1-218 to HeLa HEp-2 multicellular tumor spheroids and experimental tumors.
Jafari R; Holm P; Sandegren J; Stigbrand T; Sundström BE
Cancer Biother Radiopharm; 2010 Aug; 25(4):455-63. PubMed ID: 20707717
[TBL] [Abstract][Full Text] [Related]
8. Targeting strategies for cancer radiotherapy.
Buchsbaum DJ; Rogers BE; Khazaeli MB; Mayo MS; Milenic DE; Kashmiri SV; Anderson CJ; Chappell LL; Brechbiel MW; Curiel DT
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
[TBL] [Abstract][Full Text] [Related]
9. Studies of the interactions between the anticytokeratin 8 monoclonal antibody TS1, its antigen and its anti-idiotypic antibody alphaTS1.
Erlandsson A; Holm P; Ullén A; Stigbrand T; Sundström BE
J Mol Recognit; 2003; 16(3):157-63. PubMed ID: 12833571
[TBL] [Abstract][Full Text] [Related]
10. Anti-antibody enhancement of iodine-131 anti-CEA radioimmunodetection in experimental and clinical studies.
Goldenberg DM; Sharkey RM; Ford E
J Nucl Med; 1987 Oct; 28(10):1604-10. PubMed ID: 3498807
[TBL] [Abstract][Full Text] [Related]
11. Optimizing bispecific antibody pretargeting for use in radioimmunotherapy.
Sharkey RM; Karacay H; Richel H; McBride WJ; Rossi EA; Chang K; Yeldell D; Griffiths GL; Hansen HJ; Goldenberg DM
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3897S-913S. PubMed ID: 14506188
[TBL] [Abstract][Full Text] [Related]
12. In vivo clearing of idiotypic antibodies with antiidiotypic antibodies and their derivatives.
Erlandsson A; Eriksson D; Johansson L; Riklund K; Stigbrand T; Sundström BE
Mol Immunol; 2006 Feb; 43(6):599-606. PubMed ID: 15978666
[TBL] [Abstract][Full Text] [Related]
13. Improved biodistribution of 125I-labeled anti-Tac disulfide-stabilized Fv fragment by blocking its binding to the alpha subunit of the interleukin 2 receptor in the circulation with preinjected humanized anti-Tac IgG.
Kobayashi H; Yoo TM; Drumm D; Kim MK; Sun BF; Le N; Webber KO; Pastan I; Waldmann TA; Paik CH; Carrasquillo JA
Cancer Res; 1997 May; 57(10):1955-61. PubMed ID: 9157991
[TBL] [Abstract][Full Text] [Related]
14. Biodistribution of 18F- and 125I-labeled anti-Tac disulfide-stabilized Fv fragments in nude mice with interleukin 2 alpha receptor-positive tumor xenografts.
Choi CW; Lang L; Lee JT; Webber KO; Yoo TM; Chang HK; Le N; Jagoda E; Paik CH; Pastan I
Cancer Res; 1995 Nov; 55(22):5323-9. PubMed ID: 7585595
[TBL] [Abstract][Full Text] [Related]
15. Combinations of nonlabeled, 125I-labeled, and anti-idiotypic antiplacental alkaline phosphatase monoclonal antibodies at experimental radioimmunotargeting.
Rossi Norrlund R; Holback D; Johansson L; Hietala SO; Ahlström KR
Acta Radiol; 1997 Nov; 38(6):1087-93. PubMed ID: 9394676
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.
Wong JY; Thomas GE; Yamauchi D; Williams LE; Odom-Maryon TL; Liu A; Esteban JM; Neumaier M; Dresse S; Wu AM; Primus FJ; Shively JE; Raubitschek AA
J Nucl Med; 1997 Dec; 38(12):1951-9. PubMed ID: 9430476
[TBL] [Abstract][Full Text] [Related]
17. Enhanced radioimmunotargeting of 125I-labeled L6-biotin monoclonal antibody (MAb) by combining preload of cold L6 MAb and subsequent immunoadsorption in rats.
Garkavij M; Tennvall J; Strand SE; Norrgren K; Lindgren L; Nilsson R; Sjögren HO
Cancer Res; 1995 Dec; 55(23 Suppl):5874s-5880s. PubMed ID: 7493363
[TBL] [Abstract][Full Text] [Related]
18. Improved targeting of pancreatic cancer: experimental studies of a new bispecific antibody, pretargeting enhancement system for immunoscintigraphy.
Cardillo TM; Karacay H; Goldenberg DM; Yeldell D; Chang CH; Modrak DE; Sharkey RM; Gold DV
Clin Cancer Res; 2004 May; 10(10):3552-61. PubMed ID: 15161715
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral distribution of radiolabeled antibody and radioimmunotherapy in experimental liver metastases model of nude mouse.
Sato N; Saga T; Sakahara H; Yao Z; Nakamoto Y; Zhang M; Kuroki M; Matsuoka Y; Iida Y; Konishi J
J Nucl Med; 1999 Apr; 40(4):685-92. PubMed ID: 10210230
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing anti-antibody enhancement of tumor targeting with antibodies in hamsters with human colonic tumor xenografts.
Sharkey RM; Mabus J; Goldenberg DM
Cancer Res; 1988 Apr; 48(8):2005-9. PubMed ID: 3258181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
